Metronidazole Vioser

Metronidazole, the active ingredient in Metronidazole Vioser, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It is employed to treat anaerobic bacterial infections and specific protozoal infections such as bacterial vaginosis, trichomoniasis, amoebiasis, and Clostridioides difficile infection in hospitalized patients.

GNH USA supplies Metronidazole Vioser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured intravenous antibiotics for diverse therapeutic needs through established distribution networks and regulatory‑compliant logistics.

Metronidazole is used to treat infections caused by anaerobic bacteria and susceptible protozoa. - Anaerobic bacterial infections: effective against mixed‑flora intra‑abdominal and pelvic infections. - Bacterial vaginosis: eradicates Gardnerella and associated anaerobes. - Trichomoniasis: eliminates Trichomonas vaginalis infection. - Amoebiasis: treats intestinal Entamoeba histolytica infection. - Clostridioides difficile infection (adjunct): used as adjunctive therapy in severe cases.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools during therapy. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Stevens‑Johnson syndrome: severe skin reaction with blistering and detachment.

Before using Metronidazole Vioser, consider the following precautions. - Assess renal function: adjust use in patients with renal impairment. - Monitor hepatic function: exercise caution in liver disease. - Evaluate for hypersensitivity: discontinue if allergic reaction occurs. - Avoid alcohol: may cause a disulfiram‑like reaction. - Use in pregnancy only if benefit outweighs risk: limited safety data. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with several medicines.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Lithium: increased risk of lithium toxicity. - Warfarin: enhanced anticoagulant effect, monitor INR.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma levels. - Rifampin: may reduce metronidazole concentrations, decreasing efficacy.